AdvanSix Inc
NYSE:ASIX
AdvanSix Inc
Advansix, Inc. engages in the development and production of nylon resin products and other additives. The company is headquartered in Parsippany, New Jersey and currently employs 1,375 full-time employees. The company went IPO on 2016-09-14. The company also sells caprolactam, ammonium sulfate fertilizer, acetone and other intermediate chemicals, all of which are produced within unit operations across its integrated manufacturing value chain. The company sells its Nylon 6 resin globally, primarily under the Aegis brand name. In addition, its Nylon 6 resin is used to produce nylon films which it sells to its customers primarily under the Capran brand name. Caprolactam is the key monomer used in the production of Nylon 6 resin. Its Ammonium sulfate fertilizer is derived from the caprolactam manufacturing process and sells ammonium sulfate primarily to North American and South American distributors.
Advansix, Inc. engages in the development and production of nylon resin products and other additives. The company is headquartered in Parsippany, New Jersey and currently employs 1,375 full-time employees. The company went IPO on 2016-09-14. The company also sells caprolactam, ammonium sulfate fertilizer, acetone and other intermediate chemicals, all of which are produced within unit operations across its integrated manufacturing value chain. The company sells its Nylon 6 resin globally, primarily under the Aegis brand name. In addition, its Nylon 6 resin is used to produce nylon films which it sells to its customers primarily under the Capran brand name. Caprolactam is the key monomer used in the production of Nylon 6 resin. Its Ammonium sulfate fertilizer is derived from the caprolactam manufacturing process and sells ammonium sulfate primarily to North American and South American distributors.
Strong Q4 Close: AdvanSix ended 2025 with solid execution, achieving $157 million in full year adjusted EBITDA and $6 million in free cash flow despite challenging markets.
Revenue Growth: Q4 sales rose 9% year-over-year, driven by an 11% increase in sales volume, particularly due to the prior year's turnaround impact.
Margin Trends: Adjusted EBITDA margin for 2025 expanded by 90 basis points to 10.3%, supported by plant nutrient strength and improved production, despite input cost pressures.
Operational Records: The company achieved record annual production in both ammonia and sulfuric acid units.
Input Cost Headwinds: Significantly higher sulfur and natural gas prices are expected to be a headwind in the first half of 2026, with a projected $8–$10 million unfavorable Q1 earnings impact, which management aims to offset by year-end.
CapEx Reduction: 2026 capital expenditure is expected to decrease to $75–$95 million from $116 million in 2025, reflecting a more disciplined and risk-based approach.
Ongoing Productivity: A new fixed cost reduction initiative targets $30 million in annual run-rate savings.
Positive Outlook for Plant Nutrients: Continued demand and pricing strength in plant nutrients, while nylon remains in a cyclical trough but with signs of global capacity rationalization.
